MOESM2 of Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma

Additional file 2: Table S2. Correlation and conversion of PODXL expression between paired tissue samples in the neoadjuvant cohort.